Literature DB >> 17143749

Comparative in vitro evaluation of microspherical embolisation agents.

Andrew L Lewis1, Clementine Adams, Wendy Busby, Stephen A Jones, Laura C Wolfenden, Simon W Leppard, Rosemary R Palmer, Sharon Small.   

Abstract

This study describes the comparative performance of four commercially available microspherical embolisation products: Embosphere, Embogold, Contour SE and Bead Block. A series of in vitro evaluations were designed to assess the mechanical and biological characteristics of these biomaterials. Size distribution analysis revealed sieving techniques used to fractionate the embolics produced similar size distributions. The forces required to compress Embosphere, Embogold and Bead Block were in the range 21-27.5 kPa. Contour SE was significantly more compressible at approximately 5 kPa. However, recoverability of Contour SE required several minutes in contrast to the other products, a phenomenon attributed to its macroporous structure. When time taken to reach and remain in suspension was studied, results showed that the products quickly reached equilibrium with contrast agent. Bead Block was maintained in suspension for twice as long as the other products. Catheter deliverability was assessed and found to be dependent upon both microsphere and catheter, the best combination being Bead Block delivered via the Progreat catheter. Both the blood contacting SEM and plasma coagulation time showed none of the products were pro-thrombic or pro-coagulatory, each producing comparable results. Small differences in physical properties such as compressibility, could play an important role in delivery and effectiveness of vessel blockage. Currently all products are used routinely in clinical practice.

Mesh:

Substances:

Year:  2006        PMID: 17143749     DOI: 10.1007/s10856-006-0592-x

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  10 in total

1.  Uterine artery embolization for leiomyomata.

Authors:  J B Spies; S A Ascher; A R Roth; J Kim; E B Levy; J Gomez-Jorge
Journal:  Obstet Gynecol       Date:  2001-07       Impact factor: 7.661

2.  Trisacryl gelatin microspheres for therapeutic embolization, I: development and in vitro evaluation.

Authors:  A Laurent; R Beaujeux; M Wassef; D Rüfenacht; E Boschetti; J J Merland
Journal:  AJNR Am J Neuroradiol       Date:  1996-03       Impact factor: 3.825

3.  Clinical study of embolization of arteriovenous malformation in the oral and maxillofacial region.

Authors:  D Liu; X C Ma
Journal:  Chin J Dent Res       Date:  2000-11

Review 4.  Gelatin sponge in therapeutic neuroradiology: a subject review.

Authors:  A Berenstein; E Russell
Journal:  Radiology       Date:  1981-10       Impact factor: 11.105

5.  The treatment of hyperparathyroidism by transcatheter techniques.

Authors:  J L Doppman
Journal:  Cardiovasc Intervent Radiol       Date:  1980       Impact factor: 2.740

6.  Intravascular occlusive therapy: use of interventional radiology in cancer patients.

Authors:  S Wallace; H M Goldstein
Journal:  Postgrad Med       Date:  1976-02       Impact factor: 3.840

7.  Polyvinyl alcohol (Ivalon)--a new embolic material.

Authors:  S M Tadavarthy; J H Moller; K Amplatz
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1975-11

8.  A randomized clinical trial comparing autologous blood clot and gelfoam in transarterial chemoembolization for inoperable hepatocellular carcinoma.

Authors:  P C Kwok; T W Lam; S C Chan; C P Chung; W K Wong; M K Chan; H Y Lo; W M Lam
Journal:  J Hepatol       Date:  2000-06       Impact factor: 25.083

9.  Location of vessel occlusion of calibrated tris-acryl gelatin microspheres for tumor and arteriovenous malformation embolization.

Authors:  Alexandre Laurent; Michel Wassef; René Chapot; Emmanuel Houdart; Jean-Jacques Merland
Journal:  J Vasc Interv Radiol       Date:  2004-05       Impact factor: 3.464

10.  Particle embolization for hepatocellular carcinoma.

Authors:  K T Brown; A B Nevins; G I Getrajdman; L A Brody; R C Kurtz; Y Fong; L H Blumgart
Journal:  J Vasc Interv Radiol       Date:  1998 Sep-Oct       Impact factor: 3.464

  10 in total
  19 in total

1.  Transcatheter arterial embolization of hypervascular tumors with HepaSphere: prospective multicenter open label clinical trial of microspheres in Japan.

Authors:  Takao Hiraki; Jun Koizumi; Yasuaki Arai; Yasuo Sakurai; Hiromitsu Kumada; Yoshihiro Nambu; Shinichi Hori
Journal:  Jpn J Radiol       Date:  2015-06-26       Impact factor: 2.374

Review 2.  Advances in Biomaterials and Technologies for Vascular Embolization.

Authors:  Jingjie Hu; Hassan Albadawi; Brian W Chong; Amy R Deipolyi; Rahul A Sheth; Ali Khademhosseini; Rahmi Oklu
Journal:  Adv Mater       Date:  2019-06-06       Impact factor: 30.849

Review 3.  Polymeric materials for embolic and chemoembolic applications.

Authors:  Azadeh Poursaid; Mark Martin Jensen; Eugene Huo; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2016-02-26       Impact factor: 9.776

4.  Preparation and characterization of ketoprofen-loaded microspheres for embolization.

Authors:  Chao Zhou; Daichao Cui; Yuan Zhang; Huiyan Yuan; Tianyuan Fan
Journal:  J Mater Sci Mater Med       Date:  2011-11-22       Impact factor: 3.896

5.  Development of "imageable" beads for transcatheter embolotherapy.

Authors:  Karun V Sharma; Matthew R Dreher; Yiqing Tang; William Pritchard; Oscar A Chiesa; John Karanian; Jennifer Peregoy; Babak Orandi; David Woods; Danielle Donahue; Juan Esparza; Guy Jones; Sean L Willis; Andrew L Lewis; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2010-06       Impact factor: 3.464

6.  Anti-tumour effects of transcatheter arterial embolisation administered in combination with thalidomide in a rabbit VX2 liver tumour model.

Authors:  A Nitta-Seko; N Nitta; A Sonoda; H Otani; K Tsuchiya; S Ohta; M Takahashi; K Murata
Journal:  Br J Radiol       Date:  2010-10-19       Impact factor: 3.039

7.  Characterisation of physico-mechanical properties and degradation potential of calcium alginate beads for use in embolisation.

Authors:  Richard E J Forster; Frank Thürmer; Christine Wallrapp; Andrew W Lloyd; Wendy Macfarlane; Gary J Phillips; Jean-Pierre Boutrand; Andrew L Lewis
Journal:  J Mater Sci Mater Med       Date:  2010-04-22       Impact factor: 3.896

8.  Pattern of retained contrast on immediate postprocedure computed tomography (CT) after particle embolization of liver tumors predicts subsequent treatment response.

Authors:  Xiaodong Wang; Joseph P Erinjeri; Xiaoyu Jia; Mithat Gonen; Karen T Brown; Constantinos T Sofocleous; George I Getrajdman; Lynn A Brody; Raymond H Thornton; Majid Maybody; Ann M Covey; Robert H Siegelbaum; William Alago; Stephen B Solomon
Journal:  Cardiovasc Intervent Radiol       Date:  2012-11-14       Impact factor: 2.740

9.  Doxorubicin eluting beads - 1: effects of drug loading on bead characteristics and drug distribution.

Authors:  Andrew L Lewis; M Victoria Gonzalez; Simon W Leppard; Joanna E Brown; Peter W Stratford; Gary J Phillips; Andrew W Lloyd
Journal:  J Mater Sci Mater Med       Date:  2007-05-05       Impact factor: 3.896

10.  Tri-acryl gelatin microsphere is better than polyvinyl alcohol in the treatment of uterine myomas with uterine artery embolization.

Authors:  Yu Gao; Fang Jiang; Xinbo Wang
Journal:  Int J Clin Exp Med       Date:  2015-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.